| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2016 | AYTU Aytu Biopharma, Inc | Cantrell Gary | Director | Buy | 33,333 | $1.50 | $49,999.50 | +51.3% | |
| Nov 2, 2016 | AYTU Aytu Biopharma, Inc | Disbrow Joshua R.57 | Chief Executive Officer | Buy | 166,666 | $1.50 | $249,999.00 | +60.4% | |
| Nov 2, 2016 | MRK Merck & Co., Inc. | Lazarus Rochelle B | Director | Sell | 20,000 | $59.06 | $1,181,200.00 | -81.3% | |
| Nov 1, 2016 | ESPR Esperion Therapeutics, Inc. | Lalwani Narendra D. | Chief Operating Officer | Buy | 5,000 | $9.93 | $49,650.00 | New | |
| Nov 1, 2016 | RMTI Rockwell Medical, Inc. | Holt Kenneth L | Director | Sell | 1,400 | $5.92 | $8,288.00 | -3.5% | |
| Nov 1, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 400 | $18.09 | $7,236.00 | -0.7% | |
| Oct 31, 2016 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Buy | 84,615 | $13.00 | $1,099,995.00 | +3.4% | |
| Oct 31, 2016 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 339 | $13.00 | $4,407.00 | -0.5% | |
| Oct 24, 2016 | PRGO Perrigo Co Plc | Brown Judy L | EVP, Business Ops &CFO | Sell | 2,092 | $90.42 | $189,158.64 | -14.7% | |
| Oct 21, 2016 | JNJ Johnson & Johnson | Prince Charles | Director | Buy | 875 | $114.11 | $99,846.25 | +3.4% | |
| Oct 21, 2016 | RMTI Rockwell Medical, Inc. | Holt Kenneth L | Director | Sell | 2,533 | $6.04 | $15,299.30 | -3.0% | |
| Oct 17, 2016 | CANN Trees Corp (colorado) | Frichtel Robert Lawrence | Chief Executive Officer | Sell | 75,000 | $3.59 | $268,900.00 | -2.0% | |
| Oct 12, 2016 | CANN Trees Corp (colorado) | Frichtel Robert Lawrence | Chief Executive Officer | Sell | 25,000 | $3.71 | $92,800.00 | -1.2% | |
| Oct 5, 2016 | LLY Eli Lilly & Co | Crowe Maria A | President, Mfg. Operations | Sell | 2,248 | $81.37 | $182,926.61 | -1.2% | |
| Oct 3, 2016 | SNY Sanofi | Sanofi | 10% Owner | Buy | 450,000 | $15.00 | $6,750,000.00 | +14.0% | |
| Oct 3, 2016 | MRK Merck & Co., Inc. | Graddick Weir Mirian M | Exe V-p, Hr | Sell | 40,800 | $62.07 | $2,532,582.48 | -31.6% | |
| Oct 3, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 400 | $18.75 | $7,500.00 | -0.7% | |
| Oct 3, 2016 | AKBA Akebia Therapeutics, Inc. | Nash Duane | Director | Sell | 1,981 | $8.96 | $17,746.00 | -6.7% | |
| Oct 1, 2016 | AKBA Akebia Therapeutics, Inc. | Dahan Michel59 | SVP, Chief Business Officer | Sell | 1,401 | $8.95 | $12,545.67 | -1.9% | |
| Oct 1, 2016 | AKBA Akebia Therapeutics, Inc. | Hadas Nicole R.60 | SVP, General Counsel, Sec. | Sell | 1,556 | $8.95 | $13,933.67 | -1.8% | |
| Sep 30, 2016 | EGRX Eagle Pharmaceuticals, Inc. | Proquest Investments Iv, L.P. | 10% Owner | Sell | 22,100 | $70.06 | $1,548,326.00 | -0.5% | |
| Sep 29, 2016 | EGRX Eagle Pharmaceuticals, Inc. | Proquest Investments Iv, L.P. | 10% Owner | Sell | 77,900 | $70.04 | $5,456,116.00 | -1.7% | |
| Sep 29, 2016 | TLPH Talphera, Inc. | Perceptive Advisors LLC51 | 10% Owner | Sell | 216,500 | $3.92 | $849,496.84 | -2.0% | |
| Sep 26, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Shandell Jason B. | President And General Counsel | Sell | 56,996 | $19.50 | $1,111,268.11 | -21.9% | |
| Sep 26, 2016 | PRGO Perrigo Co Plc | Farrington Thomas | EVP And CIO | Sell | 1,110 | $96.76 | $107,403.60 | -27.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.